AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 292.68 |
Market Cap | 23.79B |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | 6.73 |
PE Ratio (ttm) | 48.81 |
Forward PE | n/a |
Analyst | Strong Buy |
Ask | 352.72 |
Volume | 326,705 |
Avg. Volume (20D) | 612,875 |
Open | 340.11 |
Previous Close | 339.60 |
Day's Range | 325.05 - 341.84 |
52-Week Range | 265.00 - 413.70 |
Beta | undefined |
About WST
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom so...
Analyst Forecast
According to 6 analyst ratings, the average rating for WST stock is "Strong Buy." The 12-month stock price forecast is $400, which is an increase of 21.77% from the latest price.
Next Earnings Release
Analysts project revenue of $764.90M, reflecting a 4.49% YoY growth and earnings per share of 1.84, making a 0.55% increase YoY.
2 months ago · seekingalpha.com
West Pharmaceutical Services, Inc. (WST) Q3 2024 Earnings Call TranscriptWest Pharmaceutical Services, Inc. (NYSE:WST ) Q3 2024 Results Earnings Conference Call October 24, 2024 9:00 AM ET Company Participants John Sweeney - Vice President, Investor Relations Eric Green - ...